Begin main content

Search

We found 5943 result(s)

2019 CADTH Symposium

Event Date: April 14, 2019 - April 16, 2019
Result type: Events

CADTH will be hosting its annual Symposium at the Shaw Centre in Edmonton, Alberta, from April 14 to 16, 2019. For more information, please visit the CADTH Symposium website. Questions may be sent by email to symposium@cadth.ca.

CADTH Drug Portfolio Information Session

Event Date: November 1, 2018
Result type: Events

This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from CADTH’s pharmaceutical reviews portfolio, including the CADTH Common Drug Review (CDR), the CADTH pan-Canadian Oncology Drug Review (pCODR), and Therapeutic Reviews. Updates on other relevant CAD...

CADTH Medical Devices Portfolio Information Session

Event Date: November 1, 2018
Result type: Events

Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will cover the role of HTA in the management of medical devices in Canada, the programs in CADTH’s medical devices and clinical interventions portfolio, the assessment processes CADTH follows, and the opportunities for input ...

crisaborole (Eucrisa)

Last Updated: October 17, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: crisaborole
Indications: atopic dermatitis

  • Brand Name: Eucrisa
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: SR0570-000
  • Project Status: Active
  • Submission Type: New

Tags

Dermatology, Dermatology

edaravone (Radicava)

Last Updated: October 17, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: edaravone
Indications: amyotrophic lateral sclerosis

  • Brand Name: Radicava
  • Manufacturer: Mitsubishi Tanabe Pharma Corporation
  • Project Number: SR0573-000
  • Project Status: Active
  • Submission Type: New

Tags

Nervous System, Nervous system

ozenoxacin (Ozanex)

Last Updated: October 17, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: ozenoxacin
Indications: Impetigo

  • Brand Name: Ozanex
  • Manufacturer: Ferrer Internacional, S.A.
  • Project Number: SR0553-000
  • Project Status: Active
  • Submission Type: New

Tags

Dermatology, Pediatrics, Impetigo, Dermatology, Pediatrics, Ozanex; ozenoxacin; Xepi; impetigo; Pediatric; Paediatric; Child

lixisenatide + insulin glargine (Soliqua)

Last Updated: October 17, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: lixisenatide + insulin glargine
Indications: Diabetes mellitus, Type 2

  • Brand Name: Soliqua
  • Manufacturer: sanofi-aventis Canada Inc.
  • Project Number: SR0564-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Diabetes Mellitus, Diabetes, Diabetes; Diabetic; soliqua; suliqua; iglarlixi; Lantus; glargine; lixisenatide; Lyxumia

cladribine (Mavenclad)

Last Updated: October 17, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: cladribine
Indications: Multiple Sclerosis, relapsing

  • Brand Name: Mavenclad
  • Manufacturer: EMD Serono, a Division of EMD Inc., Canada
  • Project Number: SR0546-000
  • Project Status: Active
  • Submission Type: New

Tags

Multiple Sclerosis, Nervous System, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple sclerosis, Nervous system, Multiple sclerosis, cladribine; RRMS

tapentadol hydrochloride (Nucynta)

Last Updated: October 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: tapentadol hydrochloride
Indications: pain, severe

  • Brand Name: Nucynta
  • Manufacturer: Paladin Labs Inc.
  • Project Number: SR0563-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Pain Management, Pain management

dexamethasone (Ozurdex)

Last Updated: October 17, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: dexamethasone
Indications: Diabetic macular edema

  • Brand Name: Ozurdex
  • Manufacturer: Allergan Inc.
  • Project Number: SR0535-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Eye, Dexamethasone, Diabetic Retinopathy, Diabetes, Ozurdex; DME; diabetic macular edema; diabetic macular oedema